338 related articles for article (PubMed ID: 20127799)
1. A mouse line expressing Sall1-driven inducible Cre recombinase in the kidney mesenchyme.
Inoue S; Inoue M; Fujimura S; Nishinakamura R
Genesis; 2010 Mar; 48(3):207-12. PubMed ID: 20127799
[TBL] [Abstract][Full Text] [Related]
2. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
[TBL] [Abstract][Full Text] [Related]
3. Identification of kidney mesenchymal genes by a combination of microarray analysis and Sall1-GFP knockin mice.
Takasato M; Osafune K; Matsumoto Y; Kataoka Y; Yoshida N; Meguro H; Aburatani H; Asashima M; Nishinakamura R
Mech Dev; 2004 Jun; 121(6):547-57. PubMed ID: 15172686
[TBL] [Abstract][Full Text] [Related]
4. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
[TBL] [Abstract][Full Text] [Related]
6. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
7. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
8. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
9. Temporal regulation of Cre recombinase activity in neural stem cells.
Imayoshi I; Ohtsuka T; Metzger D; Chambon P; Kageyama R
Genesis; 2006 May; 44(5):233-8. PubMed ID: 16652364
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice for conditional gene manipulation in astroglial cells.
Slezak M; Göritz C; Niemiec A; Frisén J; Chambon P; Metzger D; Pfrieger FW
Glia; 2007 Nov; 55(15):1565-76. PubMed ID: 17823970
[TBL] [Abstract][Full Text] [Related]
11. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the fate of cell lineages generated from cells that express the Wnt4 gene by time-lapse during kidney development.
Shan J; Jokela T; Skovorodkin I; Vainio S
Differentiation; 2010 Jan; 79(1):57-64. PubMed ID: 19740593
[TBL] [Abstract][Full Text] [Related]
14. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
Hayashi S; McMahon AP
Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
[TBL] [Abstract][Full Text] [Related]
15. Smooth muscle expression of Cre recombinase and eGFP in transgenic mice.
Xin HB; Deng KY; Rishniw M; Ji G; Kotlikoff MI
Physiol Genomics; 2002 Sep; 10(3):211-5. PubMed ID: 12209023
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-inducible gene deletion in the cardiac conduction system.
Hoesl E; Stieber J; Herrmann S; Feil S; Tybl E; Hofmann F; Feil R; Ludwig A
J Mol Cell Cardiol; 2008 Jul; 45(1):62-9. PubMed ID: 18538341
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium.
el Marjou F; Janssen KP; Chang BH; Li M; Hindie V; Chan L; Louvard D; Chambon P; Metzger D; Robine S
Genesis; 2004 Jul; 39(3):186-93. PubMed ID: 15282745
[TBL] [Abstract][Full Text] [Related]
18. Generation of transgenic mice expressing Cre recombinase under the control of the Dll1 mesoderm enhancer element.
Wehn AK; Gallo PH; Chapman DL
Genesis; 2009 May; 47(5):309-13. PubMed ID: 19298012
[TBL] [Abstract][Full Text] [Related]
19. Cre recombinase-mediated gene targeting of mesenchymal cells.
Florin L; Alter H; Gröne HJ; Szabowski A; Schütz G; Angel P
Genesis; 2004 Mar; 38(3):139-44. PubMed ID: 15048811
[TBL] [Abstract][Full Text] [Related]
20. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
